{"protocolSection": {"identificationModule": {"nctId": "NCT01478360", "orgStudyIdInfo": {"id": "CAIN457D2204"}, "organization": {"fullName": "Novartis", "class": "INDUSTRY"}, "briefTitle": "Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma", "officialTitle": "A Randomized, Double-blind, Placebo Controlled, Multiple Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Intravenous Administration of Secukinumab (AIN457) in Patients With Asthma Not Adequately Controlled With Inhaled Corticosteroids and Long Acting Beta-agonists."}, "statusModule": {"statusVerifiedDate": "2015-10", "overallStatus": "TERMINATED", "whyStopped": "Further investigations would require changes in study design; the use of different endpoints, a different IL-17 antibody or a different patient population.", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2012-03"}, "primaryCompletionDateStruct": {"date": "2014-11", "type": "ACTUAL"}, "completionDateStruct": {"date": "2014-11", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-11-17", "studyFirstSubmitQcDate": "2011-11-22", "studyFirstPostDateStruct": {"date": "2011-11-23", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2015-10-20", "resultsFirstSubmitQcDate": "2015-10-20", "resultsFirstPostDateStruct": {"date": "2015-11-20", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2015-10-20", "lastUpdatePostDateStruct": {"date": "2015-11-20", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Novartis Pharmaceuticals", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "This study is a preliminary proof of efficacy study of AIN457 in patients with bronchial asthma that is poorly controlled with the current standard of care."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["Asthma", "Secukinumab", "Therapeutic Uses", "Respiratory", "Lung", "Pulmonary", "inhaled", "corticosteroids"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 46, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "AIN457", "type": "EXPERIMENTAL", "description": "AIN457 10 mg/kg", "interventionNames": ["Drug: AIN457 (secukinumab)"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Placebo intravenous injection", "interventionNames": ["Drug: Placebo"]}], "interventions": [{"type": "DRUG", "name": "AIN457 (secukinumab)", "description": "Secukinumab intravenous injection", "armGroupLabels": ["AIN457"]}, {"type": "DRUG", "name": "Placebo", "description": "Placebo intravenous injection", "armGroupLabels": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Improvement in the Severity of Asthma as Measured by Change in the Asthma Control Questionnaire (ACQ) Score", "description": "The ACQ scores range from 0 to 6 with lower scores reflecting better asthma control. Without loss of generality, as Day 85 minus baseline (Visit 3) so that improvements in asthma control translate to negative change scores.", "timeFrame": "Baseline and 85 Days"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Adult patients with asthma \\>1 year duration diagnosed according to the GINA guidelines (GINA 2010).\n* Daily treatment with \\> 1000\u03bcg beclomethasone dipropionate or equivalent, plus a long acting beta agonist for \u2265 3 months prior to Day 1, that has been stable for at least 4 weeks prior to screening.\n* Asthma which is not adequately controlled on current treatment\n* Peripheral blood eosinophil count \\< 400/\u03bcl at screening\n\nExclusion Criteria:\n\n* Women of child-bearing potential unwilling to use effective contraception during the study and for 16 weeks after stopping treatment.\n* Use of other investigational drugs at the time of screening, or within 30 days of screening.\n* Smokers", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "maximumAge": "75 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Novartis Pharmaceuticals", "affiliation": "Novartis Pharmaceuticals", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "Novartis Investigative Site", "city": "Berlin", "zip": "10117", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "Novartis Investigative Site", "city": "Frankfurt", "zip": "60596", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "Novartis Investigative Site", "city": "Grosshansdorf", "zip": "22927", "country": "Germany", "geoPoint": {"lat": 53.66667, "lon": 10.28333}}, {"facility": "Novartis Investigative Site", "city": "Mainz", "zip": "55131", "country": "Germany", "geoPoint": {"lat": 49.98419, "lon": 8.2791}}, {"facility": "Novartis Investigative Site", "city": "Wiesbaden", "zip": "65187", "country": "Germany", "geoPoint": {"lat": 50.08258, "lon": 8.24932}}, {"facility": "Novartis Investigative Site", "city": "Leicester", "zip": "LE3 9QP", "country": "United Kingdom", "geoPoint": {"lat": 52.6386, "lon": -1.13169}}, {"facility": "Novartis Investigative Site", "city": "London", "zip": "SE11YR", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "Novartis Investigative Site", "city": "London", "zip": "SW3 6PH", "country": "United Kingdom", "geoPoint": {"lat": 51.50853, "lon": -0.12574}}, {"facility": "Novartis Investigative Site", "city": "Manchester", "zip": "M23 9QZ", "country": "United Kingdom", "geoPoint": {"lat": 53.48095, "lon": -2.23743}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "AIN457", "description": "AIN457 10 mg/kg"}, {"id": "FG001", "title": "Placebo", "description": "Placebo intravenous injection"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "PD (Pharmacodynamic) Analysis Set", "achievements": [{"groupId": "FG000", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "PK (Pharmacokinetics) Analysis Set", "achievements": [{"groupId": "FG000", "comment": "Serum samples were collected during the study and analyzed only for the AIN457 group", "numSubjects": "31"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "29"}, {"groupId": "FG001", "numSubjects": "12"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "3"}]}], "dropWithdraws": [{"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Administrative problems", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "AIN457", "description": "AIN457 10 mg/kg"}, {"id": "BG001", "title": "Placebo", "description": "Placebo intravenous injection"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "46"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "49.8", "spread": "11.62"}, {"groupId": "BG001", "value": "46.2", "spread": "10.40"}, {"groupId": "BG002", "value": "48.6", "spread": "11.25"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "16"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "23"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "15"}, {"groupId": "BG001", "value": "8"}, {"groupId": "BG002", "value": "23"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Improvement in the Severity of Asthma as Measured by Change in the Asthma Control Questionnaire (ACQ) Score", "description": "The ACQ scores range from 0 to 6 with lower scores reflecting better asthma control. Without loss of generality, as Day 85 minus baseline (Visit 3) so that improvements in asthma control translate to negative change scores.", "populationDescription": "The Pharmacodynamics (PD) analysis set was used, and subjects were analyzed according to the treatment actually. The number of patients who had evaluable PD data at the particular PD assessment time point received.", "reportingStatus": "POSTED", "paramType": "LEAST_SQUARES_MEAN", "dispersionType": "90% Confidence Interval", "unitOfMeasure": "Score", "timeFrame": "Baseline and 85 Days", "groups": [{"id": "OG000", "title": "AIN457", "description": "AIN457 10 mg/kg"}, {"id": "OG001", "title": "Placebo", "description": "Placebo intravenous injection"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "29"}, {"groupId": "OG001", "value": "13"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.173", "lowerLimit": "-0.425", "upperLimit": "0.079"}, {"groupId": "OG001", "value": "-0.007", "lowerLimit": "-0.380", "upperLimit": "0.365"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValue": "0.5392", "statisticalMethod": "Mixed Models Analysis", "paramType": "Mean Difference (Net)", "paramValue": "-0.166", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.617", "ciUpperLimit": "0.285"}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "eventGroups": [{"id": "EG000", "title": "AIN457 10 mg/kg", "description": "AIN457 10 mg/kg", "seriousNumAffected": 1, "seriousNumAtRisk": 31, "otherNumAffected": 21, "otherNumAtRisk": 31}, {"id": "EG001", "title": "Placebo", "description": "Placebo", "seriousNumAffected": 2, "seriousNumAtRisk": 15, "otherNumAffected": 13, "otherNumAtRisk": 15}], "seriousEvents": [{"term": "WRIST FRACTURE", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}]}, {"term": "INTERVERTEBRAL DISC PROTRUSION", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "BASAL CELL CARCINOMA", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}], "otherEvents": [{"term": "TINNITUS", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "ABDOMINAL PAIN UPPER", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "ABDOMINAL RIGIDITY", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "CONSTIPATION", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "DIARRHOEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 15}]}, {"term": "NAUSEA", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 15}]}, {"term": "VOMITING", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 3, "numAtRisk": 15}]}, {"term": "CHILLS", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "FATIGUE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "FEELING COLD", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "VESSEL PUNCTURE SITE BRUISE", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "CYSTITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}]}, {"term": "LOWER RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 15}]}, {"term": "NASOPHARYNGITIS", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 6, "numAtRisk": 15}]}, {"term": "OTITIS EXTERNA", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "RESPIRATORY TRACT INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "VIRAL INFECTION", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "CONTUSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "NAIL INJURY", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "PERIORBITAL CONTUSION", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "BODY TEMPERATURE INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "WEIGHT INCREASED", "organSystem": "Investigations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "IRON DEFICIENCY", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "ARTHRALGIA", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}]}, {"term": "MUSCLE SPASMS", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "PAIN IN EXTREMITY", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "DIZZINESS", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "HEADACHE", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 15}]}, {"term": "ASTHMA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 7, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 15}]}, {"term": "COUGH", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "DYSPNOEA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "HAEMOPTYSIS", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 15}]}, {"term": "OROPHARYNGEAL PAIN", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "RHINORRHOEA", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 15}]}, {"term": "RASH", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}, {"term": "XANTHOMA", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 31}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 15}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "The terms and conditions of Novartis' agreements with its investigators may vary. However, Novartis does not prohibit any investigator from publishing. Any publications from a single-site are postponed until the publication of the pooled data (i.e., data from all sites) in the clinical trial or disclosure of trial results in their entirety"}, "pointOfContact": {"title": "Study Director", "organization": "Novartis Pharmaceuticals", "phone": "862-778-8300"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Belgium", "Bulgaria", "Romania", "United States"]}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}}, "hasResults": true}